Column Capital Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$6.15K Sell
25
-32
-56% -$8.76K ﹤0.01% 577
2023
Q2
$17.3K Sell
57
-68
-54% -$18.9K ﹤0.01% 461
2023
Q1
$33K Hold
125
﹤0.01% 373
2022
Q4
$30K Hold
125
0.01% 367
2022
Q3
$23K Buy
125
+25
+25% +$4.98K ﹤0.01% 368
2022
Q2
$17K Hold
100
﹤0.01% 407
2022
Q1
$25K Hold
100
﹤0.01% 376
2021
Q4
$26K Hold
100
0.01% 385
2021
Q3
$24K Hold
100
0.01% 364
2021
Q2
$21K Hold
100
﹤0.01% 379
2021
Q1
$19K Hold
100
﹤0.01% 378
2020
Q4
$16K Hold
100
﹤0.01% 402
2020
Q3
$12K Hold
100
﹤0.01% 417
2020
Q2
$9K Hold
100
﹤0.01% 489
2020
Q1
$9K Hold
100
﹤0.01% 404
2019
Q4
$14K Buy
+100
New +$13.4K 0.01% 406

Other funds holding HCA

Column Capital Advisors's HCA Position: Q3 2023 in Review

Column Capital Advisors reduced its HCA Healthcare (HCA) stake by 56% in Q3 2023, selling an estimated $8.76K and leaving 25 shares worth $6.15K. The position accounts for ﹤0.01% of the portfolio, ranked #577.

Column Capital Advisors first reported a position in HCA in Q4 2019 and has held it in 16 quarters since. The position peaked at $33K in Q1 2023. 1,000 funds tracked by Wall St. Rank hold HCA as of Q3 2023.

  • Column Capital Advisors held 25 shares of HCA Healthcare worth $6.15K as of Q3 2023.
  • Column Capital Advisors sold 32 HCA Healthcare shares in Q3 2023, an estimated $8.76K.
  • HCA Healthcare made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #577 holding.
  • Column Capital Advisors first reported a position in HCA Healthcare in Q4 2019 and has held it in 16 quarters since.
  • Column Capital Advisors's HCA Healthcare position peaked at $33K in Q1 2023.
  • 1,000 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.